IDENTIFYING AUTOANTIBODY BIOMARKERS DERIVED FROM CANCER-SPECIFIC SPLICING AND VALIDATING THEM IN PRECLINICAL AND OCCULT OVARIAN CANCER PLASMA SAMPLES

Fred Hutchinson Cancer Research Center, Seattle WA

Investigators